urine-based cancer detection

Bringing clarity and precision to cancer diagnostics through advanced nanoscale imaging and machine learning

ABOUT US

Cellens is pioneering in label-free cell analysis with nanoscale imaging and machine learning

ADDRESSING UNMET NEEDS
IN NON-INVASIVE CANCER DETECTION

VOIDED
URINE FIXATION
STANDARD LAB
PROCESSING
HIGH RESOLUTION CELL SURFACES IMAGING
MACHINE LEARNING ANALYSIS TO DETECT MALIGNANCY

PATIENT MONITORING

High recurrence (50-80%) from non-muscle-invasive bladder cancer (NMIBC, 75% of all bladder cancer cases) requires invasive surveillance exams every 3 to 6 months. The exam, cystoscopy, consists of inserting a physical probe into the bladder through the urethra so that urologists can inspect for lesions, resulting in high lifetime costs, low patient compliance, and complications from trauma to the urethra (i.e: UTIs)

Cellens introduces a high accuracy urine-based test that would reduce the frequency of invasive procedures like cystoscopy needed to monitor bladder cancer and aims to set a new standard in bladder cancer diagnostics.